Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating azacitidine in combination with cisplatin in adults with advanced non-small cell lung cancer or squamous cell carcinoma of the head and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: Loma Linda University | Conditions: Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: TERMINATED